These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Effect of urokinase on renal interstitial inflammation in rats with chronic cyclosporine A nephropathy and its possible mechanism]. Wang Y; Ma L; Tong JR; Luo ZM; He F Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):835-8. PubMed ID: 18504214 [TBL] [Abstract][Full Text] [Related]
10. Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis. Castoldi G; di Gioia C; Giollo F; Carletti R; Bombardi C; Antoniotti M; Roma F; Zerbini G; Stella A Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):335-42. PubMed ID: 26700017 [TBL] [Abstract][Full Text] [Related]
11. Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney. Yang CW; Ahn HJ; Kim WY; Shin MJ; Kim SK; Park JH; Kim YO; Kim YS; Kim J; Bang BK Kidney Int; 2001 Sep; 60(3):847-57. PubMed ID: 11532080 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of Mizoribine on Cyclosporine A nephropathy in rats. Hara S; Umino D; Someya T; Fujinaga S; Ohtomo Y; Murakami H; Shimizu T Pediatr Res; 2009 Nov; 66(5):524-7. PubMed ID: 19668109 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Duymelinck C; Deng JT; Dauwe SE; De Broe ME; Verpooten GA Kidney Int; 1998 Sep; 54(3):804-18. PubMed ID: 9734605 [TBL] [Abstract][Full Text] [Related]
14. [Role of activation of renin angiotensin system in cyclosporine A nephropathy]. Zhang GH; Zhang X; Hou FF; Wang L Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Dec; 15(12):754-7. PubMed ID: 14659064 [TBL] [Abstract][Full Text] [Related]
15. Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Kang DH; Kim YG; Andoh TF; Gordon KL; Suga S; Mazzali M; Jefferson JA; Hughes J; Bennett W; Schreiner GF; Johnson RJ Am J Physiol Renal Physiol; 2001 Apr; 280(4):F727-36. PubMed ID: 11249864 [TBL] [Abstract][Full Text] [Related]
16. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Li C; Yang CW; Kim WY; Jung JY; Cha JH; Kim YS; Kim J; Bennett WM; Bang BK Am J Physiol Renal Physiol; 2003 Feb; 284(2):F389-98. PubMed ID: 12529276 [TBL] [Abstract][Full Text] [Related]
17. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150 [TBL] [Abstract][Full Text] [Related]
19. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling. El-Mas MM; Helmy MW; Ali RM; El-Gowelli HM Toxicol Appl Pharmacol; 2015 Apr; 284(1):1-7. PubMed ID: 25656942 [TBL] [Abstract][Full Text] [Related]
20. Early and delayed effects of AST-120 on chronic cyclosporine nephropathy. Kim SH; Ghee JY; Piao S; Han DH; Song JH; Yoon HE; Choi BS; Kim J; Nishijima F; Obara K; Ishikawa N; Yang CW Nephrol Dial Transplant; 2011 May; 26(5):1502-15. PubMed ID: 20947537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]